Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
Phase 3
Completed
- Conditions
- Allergic Conjunctivitis
- Registration Number
- NCT00445874
- Lead Sponsor
- Vistakon Pharmaceuticals
- Brief Summary
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- History of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees withing the past 24 months
- Successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more
Exclusion Criteria
- Active ocular infection
- Clinically significant blepharitis
- Follicular conjunctivitis
- Pterygium
- Narrow angle glaucoma
- Dry eye dyndrome
- Ocular surgery within past 6 months
- Pregnancy or lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Ocular itching
- Secondary Outcome Measures
Name Time Method Conjunctival, ciliary, and episcieral redness; chemosis and mucous discharge; tearing and lid swelling